SCHEMBL18448787

SCHEMBL18448787

O=[N+]([O-])c1ccc(-c2nccnc2OCCc2ccccc2C2CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 8/20 0.39
▸ CYP11B2 P19099 8/20 0.39
▸ CYP19A1 P11511 7/20 0.39
▸ IDO1 P14902 1/20 0.37
▸ MAPT P10636 3/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ RIPK2 O43353 1/20 0.34
▸ GMNN O75496 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ THPO P40225 1/20 0.34
▸ MTOR P42345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18448780 0.83 PDE10A (0.35) CYP11B1CYP11B2THRBTHPORAB9A
SCHEMBL28632021 0.83 MEN1 (0.46) CYP11B1CYP11B2CYP19A1IDO1MAPT
SCHEMBL18447793 0.79 CYP11B1 (0.56) CYP11B1CYP11B2CYP19A1IDO1MAPT
SCHEMBL18448786 0.76 ADRA2A (0.44) IDO1MAPTMAPK1ALDH1A1LMNA
SCHEMBL28642927 0.75 ALDH1A1 (0.40) CYP11B1CYP11B2CYP19A1MAPTMAPK1
SCHEMBL28627402 0.73 S1PR4 (0.43) CYP11B1CYP11B2CYP19A1MAPTMAPK1
SCHEMBL18449672 0.73 KMT2A (0.47) CYP11B1CYP11B2CYP19A1IDO1MAPT
SCHEMBL22270628 0.73 LMNA (0.44) IDO1MAPTMAPK1ALDH1A1MEN1
SCHEMBL18448782 0.72 CYP19A1 (0.54) CYP11B1CYP11B2CYP19A1IDO1MAPT
SCHEMBL18447582 0.71 CNR2 (0.47) CYP19A1MAPTALDH1A1ALOX5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026050-B Novel compounds as ROR gamma modulators 格兰马克药品股份有限公司 2021-04-30 — — CN disclosed
EP-3331863-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2018-06-13 — — EP disclosed
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 — — WO disclosed
Send feedback